在微血管减压手术后,5-西胺和术后恶心和吐.
Yuantao Hou1, Hansheng Liang1, Cungang Fan2
1Department of Anesthesiology, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, China.
概括
脑脊液5-西胺 (5-HT) 水平升高与微血管减压手术后的术后恶心和吐 (PONV) 有关. 这一发现确定了这些患者PONV的关键风险因素.
科学领域:
- 神经外科 神经外科
- 麻醉学 麻醉学
- 神经科学是一个神经科学.
背景情况:
- 手术后恶心和吐 (PONV) 是微血管减压 (MVD) 手术后的常见并发症.
- 在MVD之后驱动PONV的确切机制仍然不清楚.
- 在PONV患者中观察到血清5-二三胺 (5-HT) 的升高,但其在MVD相关PONV中的作用尚不清楚.
研究的目的:
- 调查5西胺 (5-HT) 水平与在接受MVD手术的患者中PONV发生率之间的关联.
- 确定潜在的生物标志物来预测MVD后的PONV风险.
主要方法:
- 对85名接受MVD治疗的患者进行前性研究.
- 使用ELISA测量血清和脑脊液 (CSF) 中的5-HT水平.
- 在手术后2,6和24小时评估PONV发病率和严重程度.
主要成果:
- 在MVD (OR=1.21,p=0.044) 后24小时内,CSF5-HT水平升高与PONV显著相关.
- 眼内压力的降低也与PONV有关 (OR=11.54,p=0.022).
- 接收器操作特征分析显示了高预测准确度 (AUC=0.873,p<0.001).
结论:
- 大脑脊髓液5-HT水平代表了MVD手术后PONV的独立风险因素.
- 在这种患者群体中,CSF 5-HT可能作为PONV的预测生物标志物.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
242
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
242
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
199
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
199
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
314
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
314
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
332
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
332
Pathophysiology of Vomiting
608
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
608
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
303
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
303


